- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | BioSig Technologies, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 26.03. | BioSig Technologies, Inc.: BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market | 93 | GlobeNewswire (Europe) | Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) ("BioSig" or the "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac... ► Artikel lesen | |
| 25.03. | BioSig Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| BIOSIG TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 03.03. | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.01. | BioSig Technologies, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 31.12.24 | BioSig Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.24 | BioSig Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.12.24 | BioSig Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.24 | BioSig Technologies, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11.24 | BioSig Technologies, Inc.: BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement | 85 | GlobeNewswire (Europe) | Los Angeles, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or "Company"), a medical technology company delivering unprecedented accuracy and precision to... ► Artikel lesen | |
| 13.11.24 | BioSig Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.10.24 | BioSig Faces NASDAQ Delisting Over Price Deficiency | 1 | Investing.com | ||
| 29.10.24 | BioSig droht Delisting von der NASDAQ aufgrund zu niedriger Aktienkurse | 1 | Investing.com Deutsch | ||
| 29.10.24 | BioSig Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.10.24 | BioSig Technologies, Inc.: BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel | 109 | GlobeNewswire (Europe) | Los Angeles, CA, Oct. 22, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) ("BioSig" or the "Company"), a medical technology company delivering unprecedented accuracy and precision... ► Artikel lesen | |
| 22.10.24 | BioSig granted grace period to meet Nasdaq listing requirements | 1 | Investing.com | ||
| 22.10.24 | BioSig erhält Gnadenfrist zur Erfüllung der Nasdaq-Notierungsanforderungen | 1 | Investing.com Deutsch | ||
| 22.10.24 | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.07.24 | BioSig Technologies, Inc.: BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation | 176 | GlobeNewswire (Europe) | Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) ("BioSig" or "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac... ► Artikel lesen | |
| 25.07.24 | BioSig Technologies, Inc.: BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024 | 119 | GlobeNewswire (Europe) | Los Angeles, CA 90025, July 25, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) or ("BioSig" or "Company"), a medical technology company delivering unprecedented accuracy and precision... ► Artikel lesen |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,104 | -2,79 % | Sernova Biotherapeutics Inc: Sernova to continue to Cohort C T1D trial in H2 2025 | ||
| ATOSSA THERAPEUTICS | 0,556 | +0,18 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications | SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,792 | -1,32 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,022 | +23,33 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,284 | -1,39 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,886 | -1,77 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights | 2024 marked by strong commercial execution and improved operating leverage
Company continues to expect DrugSorb-ATR regulatory decisions from Health Canada and... ► Artikel lesen | |
| VERU | 0,519 | +0,48 % | Veru Aktie: Kreuzung ohne klare Richtung! | Die Veru-Aktie konnte im jüngsten Handel einen leichten Aufschwung verzeichnen. Am 22. März stieg der Kurs um 2,35% auf 0,48 EUR, was eine positive Entwicklung gegenüber dem Vortagsschluss darstellt.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,588 | +4,53 % | Tempest Therapeutics: Tempest Reports Year End 2024 Financial Results and Provides Business Update | • Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement... ► Artikel lesen | |
| VOLITIONRX | 0,560 | 0,00 % | VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Monday, March 31 at 4:30 p.m. U.S. Eastern Time HENDERSON, Nevada, March 31, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
| EKSO BIONICS | 0,355 | +0,28 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
| IMUNON | 0,860 | -2,27 % | Imunon files to sell 10M shares of common stock, warrants | ||
| BEYOND AIR | 0,214 | -3,60 % | Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site | ||
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,570 | -4,19 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 38,060 | -4,16 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.04.2025 / 14:14... ► Artikel lesen |
BIOSIG TECHNOLOGIES INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,019 (+3,71 %) liegt der Kurs bei 0,537 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOSIG TECHNOLOGIES INC finden Sie auf Wallstreet Online.
